Abstract
ObjectiveTo investigate the efficacy and safety of hu3S193, a humanized anti-Lewis-Y monoclonal antibody, as a consolidation strategy in patients with platinum-sensitive recurrent epithelial ovarian cancer who achieved a second complete...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have